Magnetic Cell Selection System for CD34+ Cells from HPC-apheresis used in Treatment of Acute Myeloid Leukemia (AML)
- Sponsor:
- National Marrow Donor Program - NMDP
- Sponsor Study ID:
- HUD: BH110018
- CTO #:
- 104296
- NCT Number:
- Phase:
- N/A
- Protocol Type:
- Device Feasibility
- Age Group:
- Adults
- Disease Sites:
- Leukemia, other; Myeloid and Monocytic Leukemia
- Study Objectives:
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Coltoff, Alexander, at coltoff@musc.edu
- Study Coordinator, Ward, Sarah, at saw306@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina